News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Little Addicts? Purdue Pharma L.P. to Test OxyContin on Kids


7/3/2012 8:44:08 AM

In a bid to extend the patent on its OxyContin painkiller by six months, Purdue Pharma is running clinical trials on more than 150 children between the ages 6 and 16 years old who have “moderate to severe” pain and would require opioid analgesics, according to reports. If the results pass muster with the FDA, the drugmaker can ring the register for another six months beyond April 2013, when the OxyContin patent expires.

Read at Pharmalot
Read at Wall Street Journal
Read at News Release

comments powered by Disqus
   
Addiction

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES